Powered by healthtechmovers.com
According to healthtechmovers.com, there are a few trending healthtech stocks that have recently received buy ratings and showing positive investor sentiment, as well as news headlines. With that said, the editors over at healthtechmovers.com, are adding the stocks below to their healthtech stock watchlist. That staff here at techstockmovers.com, will continue to monitor these healthtech companies to see if the momentum continues. Tech stocks that might be included in one of our reports may include companies like; Apple (AAPL) stock, Microsoft Corporation (MSFT) stock, Alphabet (GOOGL) stock, Meta Platforms (META) stock, and NVIDIA Corp (NVDA) stock..
Recent AMLX Stock Price: $24.69
Summary: Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.
Andrew Fein analyst at H.C. Wainwright reiterates coverage on Amylyx Pharmaceuticals Inc (AMLX) stock in the energy sector with a Buy rating and has set AMLX's stock price target at $ 50.
TipRanks.com reports that Amylyx Pharmaceuticals Inc currently has analysts offering 12-month price targets on AMLX and the consensus is a Strong Buy rating with an average stock price target of . The most recent AMLX stock price we have is $24.69 and we are not making any AMLX forecasts at this time.
In addition, TradingView issued a Sell rating for AMLX over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on AMLX. techstockmovers.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on AMLX, please click here >>
Freeline Therapeutics Holdings, FRLN
Recent FRLN Stock Price: $2.51
Summary: Freeline Therapeutics Holdings plc is a clinical-stage biotechnology company. It is focused on AAV-based gene therapy targeting the liver. The company operates principally in Germany and the U.S. Freeline Therapeutics Holdings plc is headquartered in the U.K.
Dae Gon analyst at Stifel Nicolaus reiterates coverage on Freeline Therapeutics Holdings (FRLN) stock in the energy sector with a Hold rating and has set FRLN's stock price target at $ 3.
TipRanks.com reports that Freeline Therapeutics Holdings currently has analysts offering 12-month price targets on FRLN and the consensus is a Strong Buy rating with an average stock price target of . The most recent FRLN stock price we have is $2.51 and we are not making any FRLN forecasts at this time.
In addition, TradingView issued a Sell rating for FRLN over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Bearish short-term outlook. Remember, securities are volatile, so please do your own research on FRLN. techstockmovers.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on FRLN, please click here >>
PepGen Inc., PEPG
Recent PEPG Stock Price: $14.98
Summary: PepGen Inc. is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen Inc. is based in BOSTON.
Laura Chico analyst at Wedbush reiterates coverage on PepGen Inc. (PEPG) stock in the energy sector with a Buy rating and has set PEPG's stock price target at $ 22.
TipRanks.com reports that PepGen Inc. currently has analysts offering 12-month price targets on PEPG and the consensus is a Strong Buy rating with an average stock price target of . The most recent PEPG stock price we have is $14.98 and we are not making any PEPG forecasts at this time.
In addition, TradingView issued a Buy rating for PEPG over the next month, Barchart.com has a buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on PEPG. techstockmovers.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on PEPG, please click here >>
The editors at techstockmovers.com use a variety of research tools to generate our watchlists and research reports. One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. TipRanks.com tracks and measures the performance of over 50,000 financial experts. The TipRanks Star RankingTM is calculated based on expert success rate, average return and statistical significance. Get more from TipRanks.com here >>
TechStockMovers.com keeps investors informed on a variety of tech stocks including communications equipment, IT Services, Semiconductors, Software, Technical hardware, storage and peripherals, artificial intelligence (AI), cybersecurity and more. (TSM) aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com.
==============================================================================
